Introduction

Triflo Cardiovascular is a Southern California – based biomedical company focused on delivering the best transcatheter system to treat tricuspid valve regurgitation patients regardless of the native valve’s size and anatomy.  Setting aside conventional valve technologies, our engineers have honed in on the unique features of the tricuspid valve and the right heart. The result is the Tricuspid Flow Optimizer, a unique implantable device with a minimalistic footprint and polymer leaflets that work with the native anatomy. In tandem with the Optimizer, an intuitive and easy to use transfemoral delivery system was developed in collaboration with highly experienced interventional cardiologists. Following exhaustive testing, Triflo has started clinical evaluations of the Tricuspid Flow Optimizer.